Karki Shakun, Ngo Doan T M, Farb Melissa G, Park Song Young, Saggese Samantha M, Hamburg Naomi M, Carmine Brian, Hess Donald T, Walsh Kenneth, Gokce Noyan
Evans Department of Medicine and Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts; and.
Department of General Surgery, Boston University School of Medicine, Boston, Massachusetts.
Am J Physiol Heart Circ Physiol. 2017 Jul 1;313(1):H200-H206. doi: 10.1152/ajpheart.00776.2016. Epub 2017 Apr 14.
Experimental studies have suggested that Wingless-related integration site 5A (WNT5A) is a proinflammatory secreted protein that is associated with metabolic dysfunction in obesity. Impaired angiogenesis in fat depots has been implicated in the development of adipose tissue capillary rarefaction, hypoxia, inflammation, and metabolic dysfunction. We have recently demonstrated that impaired adipose tissue angiogenesis is associated with overexpression of antiangiogenic factor VEGF-Ab in human fat and the systemic circulation. In the present study, we postulated that upregulation of WNT5A is associated with angiogenic dysfunction and examined its role in regulating VEGF-Ab expression in human obesity. We biopsied subcutaneous and visceral adipose tissue from 38 obese individuals (body mass index: 44 ± 7 kg/m, age: 37 ± 11 yr) during planned bariatric surgery and characterized depot-specific protein expression of VEGF-Ab and WNT5A using Western blot analysis. In both subcutaneous and visceral fat, VEGF-Ab expression correlated strongly with WNT5A protein ( = 0.9, < 0.001). In subcutaneous adipose tissue where angiogenic capacity is greater than in the visceral depot, exogenous human recombinant WNT5A increased VEGF-Ab expression in both whole adipose tissue and isolated vascular endothelial cell fractions ( < 0.01 and < 0.05, respectively). This was associated with markedly blunted angiogenic capillary sprout formation in human fat pad explants. Moreover, recombinant WNT5A increased secretion of soluble fms-like tyrosine kinase-1, a negative regulator of angiogenesis, in the sprout media ( < 0.01). Both VEGF-Ab-neutralizing antibody and secreted frizzled-related protein 5, which acts as a decoy receptor for WNT5A, significantly improved capillary sprout formation and reduced soluble fms-like tyrosine kinase-1 production ( < 0.05). We demonstrated a significant regulatory nexus between WNT5A and antiangiogenic VEGF-Ab in the adipose tissue of obese subjects that was linked to angiogenic dysfunction. Elevated WNT5A expression in obesity may function as a negative regulator of angiogenesis. Wingless-related integration site 5a (WNT5A) negatively regulates adipose tissue angiogenesis via VEGF-Ab in human obesity.
实验研究表明,无翅相关整合位点5A(WNT5A)是一种促炎分泌蛋白,与肥胖中的代谢功能障碍有关。脂肪库中血管生成受损与脂肪组织毛细血管稀疏、缺氧、炎症和代谢功能障碍的发展有关。我们最近证明,脂肪组织血管生成受损与人体脂肪和体循环中抗血管生成因子VEGF-Ab的过表达有关。在本研究中,我们推测WNT5A的上调与血管生成功能障碍有关,并研究了其在调节人类肥胖中VEGF-Ab表达的作用。我们在计划进行的减肥手术期间,从38名肥胖个体(体重指数:44±7kg/m,年龄:37±11岁)获取皮下和内脏脂肪组织活检样本,并使用蛋白质印迹分析来表征VEGF-Ab和WNT5A在不同脂肪库中的特异性蛋白表达。在皮下和内脏脂肪中,VEGF-Ab表达与WNT5A蛋白密切相关(r = 0.9,P < 0.001)。在血管生成能力大于内脏脂肪库的皮下脂肪组织中,外源性人重组WNT5A增加了整个脂肪组织和分离的血管内皮细胞组分中VEGF-Ab的表达(分别为P < 0.01和P < 0.05)。这与人体脂肪垫外植体中血管生成性毛细血管芽形成明显受抑制有关。此外,重组WNT5A增加了芽培养基中可溶性fms样酪氨酸激酶-1(一种血管生成的负调节因子)的分泌(P < 0.01)。VEGF-Ab中和抗体和作为WNT5A诱饵受体的分泌型卷曲相关蛋白5均显著改善了毛细血管芽形成并减少了可溶性fms样酪氨酸激酶-1的产生(P < 0.05)。我们证明了肥胖受试者脂肪组织中WNT5A与抗血管生成的VEGF-Ab之间存在显著的调节联系,这与血管生成功能障碍有关。肥胖中WNT5A表达升高可能作为血管生成的负调节因子。在人类肥胖中,无翅相关整合位点5a(WNT5A)通过VEGF-Ab对脂肪组织血管生成起负调节作用。